Tokyo Court Dismisses All Claims by Fortis Promoter NTK Against Daiichi Sankyo
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty Midcap 150 and 0.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Tokyo District Court dismissed all claims brought by Northern TK Venture (NTK), the promoter shareholder of Fortis Healthcare, against Daiichi Sankyo. NTK was ordered to bear the litigation costs. NTK disagrees with the ruling and is reviewing it with legal counsel to evaluate further remedies. The dispute is directly between NTK and Daiichi Sankyo, not involving Fortis. Fortis is sharing this because NTK is its promoter.
No direct impact on Fortis operations. Promoter NTK lost the case and must pay costs. NTK may appeal, keeping this matter open.